Literature Search

Liu(Y),Ye(S),Liu(Z),Chen(Z),Liang(X) Cancers (Basel) 2026-02-03

...MSH6, and PMS2). This approach fails to leverage gene-specific characteristics for precision healthcare delivery. This r...

Kluk(A),Gryczka(H),Braszka(M),Ałtyn(R),Marki… Int J Mol Sci 2026-01-28

...MSH6) mutations. Hereditary cancer predisposition typically follows an autosomal dominant inheritance pattern and may be...

Li(CZ),Zhou(HJ),Chen(JD),Huang(J),Liu(YX),Qi… Biochem Biophys Rep 2026-03-00

...MSH6, RN7SL1, AARS, LCP1, APP, ERLIN2, MIEF1, MEGF8, RPS2, PLK1, ENO1, DOCK8, TNRC18, DCAF7, TPT1, RPL3, CAP1, and PLK4 ...

Radom(M),Buffet(C),Cazarin(J),Harinquet(M),d… Int J Biol Sci None

...MSH6 proteins, which in cooperation with DNMT1, convert these lesions into transcription-blocking events. This mechanism...

Huang(L),Tang(X),Cao(D),Li(Y),Zhu(X) Front Oncol None

...MSH6 frameshift mutation synergistically exacerbated genomic instability, highlighting a potential mechanism for LS-driv...

Tobias(F),Sekera(ER),Xiong(X),Fang(F),Hampel… bioRxiv 2026-01-29

...MSH6, and PMS2. While the genetic changes associated with Lynch Syndrome have previously been characterized, there have ...

Jiang(S),Li(Y),Wu(S),Wan(J),Li(X) Front Immunol None

...MSH6 alterations. Younger tumors were characterized by activation of stemness and metabolic signaling pathways, whereas ...

Kim(NI),Lee(JS),Lee(KH),Kim(SS) J Ovarian Res 2026-02-07

...MSH6. Next-generation sequencing revealed ARID1A loss and somatic PIK3CA mutations. No primary ovarian, endometrial, or ...

Salzano(S),Broggi(G),Zanelli(M),Zizzo(M),Fab… Surg Oncol 2026-04-00

...MSH6 loss (60%) compared to MLH1/PMS2 loss (70%). This drop in sensitivity was attributed to the models' reluctance to c...

Jia(H),Cai(R),Liu(L),Zhang(J),Bi(Y) Am J Ophthalmol 2026-06-00

...MSH6 loss, versus none in sebaceomas (P = .013). Atypical neoplasms also shared other key clinicopathologic features wit...